News & Analysis on Clinical Trial Services & Contract Research And Development
Germany's Merck has announced its biggest investment in pharmaceuticals in its 338-year-old history, as its top-selling oncology drug Erbitux (cetuximab) has driven the company to allocate €190m for the construction of its first biopharmaceutical...
US generic drugmaker Mylan has agreed to spend around $736m (€573.4m) to acquire a controlling stake in Matrix, an Indian manufacturer of active pharmaceutical ingredients (APIs) and solid oral dosage forms, as relentless competition continues to fuel...
A new report has suggested the US demand for enzymes for pharmaceutical and biocatalyst sectors will trigger market growth of 6.9 per cent per year reaching $2.2bn (€1.7bn) in 2010.
In the first drug master file (DMF) approval of its kind, the US Food and Drug Administration (FDA) has approved the sale of metformin hydrochloride tablets which are produced by an Indian company using a pharmaceutical formulation intermediate (PFI),...
PerkinElmer has released its line of gas chromatography products, which claims to deliver the fastest injection-to-injection time in conventional gas chromatography, reducing cycle time and increasing sample throughput.
Scientists believe they have discovered a novel way in treating people suffering from anthrax poisoning, which could overcome the problem of antibiotic resistance that is becoming increasingly common in southern and Eastern Europe and Africa.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Nastech Pharmaceuticals a development grant for RNAi therapeutics to prevent and treat influenza.